🇺🇸 FDA
Patent

US 11155804

Recombinant polypeptides comprising selenocysteine and method for producing the same

granted A61KA61K38/00

Quick answer

US patent 11155804 (Recombinant polypeptides comprising selenocysteine and method for producing the same) held by The Board of Regents of the University of Texas System expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/00